References
- Li A H, Rosenquist R, Forestier E, Holmberg D, Lindh J, Löfvenberg E, Roos G. Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers. Eur J Haematol 1999; 63: 211–218
- Robertson L E, Pugh W, O'Brien S, Kantarjian H, Hirsch-Ginsberg C, Cork A, et al. Richter's syndrome: a report on 39 patients. J Clin Oncol 1993; 11: 1985–1989
- Thornton P D, Bellas C, Santon A, Shah G, Pocock C, Wotherspoon A C, et al. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leuk Res 2005; 29: 389–395
- Lazzarino M, Orlandi E, Baldanti F, Furione M, Pagnucco G, Astori C, et al. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol 1999; 107: 877–882
- Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
- Timar B, Fulop Z, Csernus B, Angster C, Bognar A, Szepesi A, et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia 2004; 18: 326–330
- Hensel M, Buss E C, Tiemann M, Parwaresch R, Libicher M, Fruehauf S, Ho A D. Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome. Eur J Haematol 2004; 72: 217–221
- Beaudreuil J, Lortholary O, Martin A, Feuillard J, Guillevin L, Lortholary P, et al. Hypercalcemia may indicate Richter's syndrome: report of four cases and review. Cancer 1997; 79: 1211–1215
- Vlasveld L T, Pauwels P, Ermens A A, Aarnoudse W H, Ooms H W, Haak H R. Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an aypical chronic lymphocytic leukemia. Neth J Med 1999; 54: 21–26
- Tian E, Zhan F, Walker R, Rasmussen E, Yupo M A, Barlogie B, Shaughnessy J D. The role of the wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003; 349: 2483–2494